{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:02:05Z","timestamp":1789527725661,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-04452-8","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:44:24Z","timestamp":1782755064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Secondary prevention of recurrent ischemic stroke: from guidelines to precision medicine"],"prefix":"10.1186","volume":"21","author":[{"given":"Shiyang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siat Yee","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"10","key":"4452_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBDS Collaborators","year":"2021","unstructured":"Collaborators GBDS. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795\u2013820.","journal-title":"Lancet Neurol"},{"issue":"15","key":"4452_CR2","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.jacc.2019.12.072","volume":"75","author":"HC Diener","year":"2020","unstructured":"Diener HC, Hankey GJ. Primary and secondary prevention of ischemic stroke and cerebral hemorrhage: JACC focus seminar. J Am Coll Cardiol. 2020;75(15):1804\u201318.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"4452_CR3","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association\/American Stroke Association. Stroke. 2021;52(7):e364\u2013467.","journal-title":"Stroke"},{"issue":"1","key":"4452_CR4","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/2396987321989865","volume":"6","author":"E Berge","year":"2021","unstructured":"Berge E, Whiteley W, Audebert H, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6(1):I\u2013LXII.","journal-title":"Eur Stroke J"},{"issue":"7","key":"4452_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","volume":"18","author":"JM Wardlaw","year":"2019","unstructured":"Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684\u201396.","journal-title":"Lancet Neurol"},{"issue":"2","key":"4452_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1747493018799981","volume":"14","author":"H Kamel","year":"2019","unstructured":"Kamel H, Longstreth WT Jr, Tirschwell DL, et al. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods. Int J Stroke. 2019;14(2):207\u201314.","journal-title":"Int J Stroke"},{"issue":"1","key":"4452_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.09.001","volume":"25","author":"S Yaghi","year":"2016","unstructured":"Yaghi S, Boehme AK, Hazan R, et al. Atrial cardiopathy and cryptogenic stroke: a cross-sectional pilot study. J Stroke Cerebrovasc Dis. 2016;25(1):110\u20134.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"23","key":"4452_CR8","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","volume":"378","author":"RG Hart","year":"2018","unstructured":"Hart RG, Sharma M, Mundl H, et al. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med. 2018;378(23):2191\u2013201.","journal-title":"N Engl J Med"},{"issue":"20","key":"4452_CR9","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","volume":"380","author":"HC Diener","year":"2019","unstructured":"Diener HC, Sacco RL, Easton JD, et al. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med. 2019;380(20):1906\u201317.","journal-title":"N Engl J Med"},{"issue":"9","key":"4452_CR10","first-page":"2750","volume":"30","author":"G Ntaios","year":"2023","unstructured":"Ntaios G, Pearce LA, Meseguer E, et al. Atrial fibrillation detection by mobile health devices after embolic stroke of undetermined source: individual participant data meta-analysis of randomized trials. Eur J Neurol. 2023;30(9):2750\u20139.","journal-title":"Eur J Neurol"},{"issue":"3","key":"4452_CR11","first-page":"317","volume":"24","author":"HM Kwon","year":"2022","unstructured":"Kwon HM, Kim BJ, Lee SH, et al. Metabolomics in ischemic stroke: a clinician perspective. J Stroke. 2022;24(3):317\u201338.","journal-title":"J Stroke"},{"issue":"1","key":"4452_CR12","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1038\/s41467-023-38603-5","volume":"14","author":"H Xu","year":"2023","unstructured":"Xu H, Westman E, Amador K, et al. Prediction of Alzheimer\u2019s disease cognitive assessment via robust and interpretable artificial intelligence. Nat Commun. 2023;14(1):2870.","journal-title":"Nat Commun"},{"issue":"20","key":"4452_CR13","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1212\/WNL.0000000000004645","volume":"89","author":"T Gattringer","year":"2017","unstructured":"Gattringer T, Enzinger C, Ropele S, et al. Serum neurofilament light is sensitive to active cerebral small vessel disease. Neurology. 2017;89(20):2108\u201314.","journal-title":"Neurology"},{"issue":"1","key":"4452_CR14","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","volume":"11","author":"M Khalil","year":"2020","unstructured":"Khalil M, Pirpamer L, Hofer E, et al. Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun. 2020;11(1):812.","journal-title":"Nat Commun"},{"issue":"2","key":"4452_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/STROKEAHA.120.029232","volume":"52","author":"FA Montellano","year":"2021","unstructured":"Montellano FA, Ungeth\u00fcm K, Ramiro L, et al. Role of blood-based biomarkers in ischemic stroke prognosis: a systematic review. Stroke. 2021;52(2):543\u201351.","journal-title":"Stroke"},{"issue":"3","key":"4452_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/2396987316654337","volume":"1","author":"A Bustamante","year":"2016","unstructured":"Bustamante A, Diaz-Fernandez B, Pagola J, et al. Admission troponin-I predicts subsequent cardiac complications and mortality in acute stroke patients. Eur Stroke J. 2016;1(3):205\u201312.","journal-title":"Eur Stroke J"},{"issue":"4","key":"4452_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/1741826711410820","volume":"19","author":"A Di Castelnuovo","year":"2012","unstructured":"Di Castelnuovo A, Costanzo S, Persichillo M, et al. Distribution of short and lifetime risks for cardiovascular disease in Italians. Eur J Prev Cardiol. 2012;19(4):723\u201330.","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"4452_CR18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/CIRCULATIONAHA.118.035905","volume":"139","author":"MK Georgakis","year":"2019","unstructured":"Georgakis MK, Gill D, Rannikm\u00e4e K, et al. Genetically determined levels of circulating cytokines and risk of stroke. Circulation. 2019;139(2):256\u201368.","journal-title":"Circulation"},{"issue":"1","key":"4452_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41588-017-0011-x","volume":"50","author":"V Turcot","year":"2018","unstructured":"Turcot V, Lu Y, Highland HM, et al. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2018;50(1):26\u201341.","journal-title":"Nat Genet"},{"issue":"26","key":"4452_CR20","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","volume":"370","author":"T Sanna","year":"2014","unstructured":"Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478\u201386.","journal-title":"N Engl J Med"},{"issue":"11","key":"4452_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"JL Mas","year":"2017","unstructured":"Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377(11):1011\u201321.","journal-title":"N Engl J Med"},{"issue":"11","key":"4452_CR22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L S\u00f8ndergaard","year":"2017","unstructured":"S\u00f8ndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033\u201342.","journal-title":"N Engl J Med"},{"issue":"1","key":"4452_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11\u20139.","journal-title":"N Engl J Med"},{"issue":"3","key":"4452_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215\u201325.","journal-title":"N Engl J Med"},{"issue":"12","key":"4452_CR25","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1001\/jamaneurol.2019.2531","volume":"76","author":"Y Pan","year":"2019","unstructured":"Pan Y, Elm JJ, Li H, et al. Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trials. JAMA Neurol. 2019;76(12):1466\u201373.","journal-title":"JAMA Neurol"},{"issue":"3","key":"4452_CR26","first-page":"235","volume":"80","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li S, Pan Y, et al. Dual antiplatelet therapy in minor stroke or transient ischemic attack with atherosclerotic stenosis within 72 hours of symptoms onset: a randomized clinical trial. JAMA Neurol. 2023;80(3):235\u201345.","journal-title":"JAMA Neurol"},{"issue":"27","key":"4452_CR27","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","volume":"385","author":"Y Wang","year":"2021","unstructured":"Wang Y, Meng X, Wang A, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med. 2021;385(27):2520\u201330.","journal-title":"N Engl J Med"},{"issue":"3","key":"4452_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1916870","volume":"383","author":"SC Johnston","year":"2020","unstructured":"Johnston SC, Amarenco P, Denison H, et al. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med. 2020;383(3):207\u201317.","journal-title":"N Engl J Med"},{"issue":"12","key":"4452_CR29","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1161\/STROKEAHA.120.032239","volume":"51","author":"P Amarenco","year":"2020","unstructured":"Amarenco P, Denison H, Evans SR, et al. Ticagrelor added to aspirin in acute non-severe ischemic stroke or transient ischemic attack of atherosclerotic origin. Stroke. 2020;51(12):3504\u201313.","journal-title":"Stroke"},{"issue":"20","key":"4452_CR30","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1212\/WNL.0000000000003941","volume":"88","author":"Y Pan","year":"2017","unstructured":"Pan Y, Jing J, Chen W, et al. Risks and benefits of clopidogrel-aspirin in minor stroke or TIA: time course analysis of CHANCE. Neurology. 2017;88(20):1906\u201311.","journal-title":"Neurology"},{"issue":"9921","key":"4452_CR31","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955\u201362.","journal-title":"Lancet"},{"issue":"10","key":"4452_CR32","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel J, Collins R, Antz M, et al. 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021;23(10):1612\u201376.","journal-title":"Europace"},{"issue":"12","key":"4452_CR33","first-page":"1117","volume":"22","author":"J Oldgren","year":"2023","unstructured":"Oldgren J, \u00c5sberg S, Hijazi Z, et al. Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (ELAN): an open-label, randomised controlled trial. Lancet Neurol. 2023;22(12):1117\u201327.","journal-title":"Lancet Neurol"},{"issue":"7","key":"4452_CR34","first-page":"576","volume":"22","author":"U Fischer","year":"2023","unstructured":"Fischer U, Gattringer T, Wetzel SG, et al. Timing of initiation of oral anticoagulants for acute ischaemic stroke in patients with atrial fibrillation. Lancet Neurol. 2023;22(7):576\u201384.","journal-title":"Lancet Neurol"},{"issue":"14","key":"4452_CR35","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","volume":"377","author":"JW Eikelboom","year":"2017","unstructured":"Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med. 2017;377(14):1319\u201330.","journal-title":"N Engl J Med"},{"issue":"1","key":"4452_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa1910355","volume":"382","author":"P Amarenco","year":"2020","unstructured":"Amarenco P, Kim JS, Labreuche J, et al. A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med. 2020;382(1):9\u201319.","journal-title":"N Engl J Med"},{"issue":"18","key":"4452_CR37","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713\u201322.","journal-title":"N Engl J Med"},{"issue":"22","key":"4452_CR38","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","volume":"379","author":"GG Schwartz","year":"2018","unstructured":"Schwartz GG, Steg PG, Szarek M, et al. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018;379(22):2097\u2013107.","journal-title":"N Engl J Med"},{"issue":"15","key":"4452_CR39","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","volume":"388","author":"SE Nissen","year":"2023","unstructured":"Nissen SE, Lincoff AM, Brennan D, et al. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients. N Engl J Med. 2023;388(15):1353\u201364.","journal-title":"N Engl J Med"},{"issue":"16","key":"4452_CR40","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","volume":"382","author":"KK Ray","year":"2020","unstructured":"Ray KK, Wright RS, Kallend D, et al. Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol. N Engl J Med. 2020;382(16):1507\u201319.","journal-title":"N Engl J Med"},{"issue":"3","key":"4452_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa1905239","volume":"382","author":"S Tsimikas","year":"2020","unstructured":"Tsimikas S, Karwatowska-Prokopczuk E, Gouni-Berthold I, et al. Lipoprotein(a) reduction in persons with cardiovascular disease. N Engl J Med. 2020;382(3):244\u201355.","journal-title":"N Engl J Med"},{"issue":"12","key":"4452_CR42","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344\u2013418.","journal-title":"Stroke"},{"issue":"11","key":"4452_CR43","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1105335","volume":"365","author":"MI Chimowitz","year":"2011","unstructured":"Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993\u20131003.","journal-title":"N Engl J Med"},{"issue":"8","key":"4452_CR44","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1161\/CIRCRESAHA.122.319951","volume":"130","author":"NS Rost","year":"2022","unstructured":"Rost NS, Brodtmann A, Pase MP, et al. Post-stroke cognitive impairment and dementia. Circ Res. 2022;130(8):1252\u201371.","journal-title":"Circ Res"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04452-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04452-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04452-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:02:11Z","timestamp":1789524131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04452-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4452"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04452-8","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"703"}}